• Fox Chase Surgeon Passes it on to the Next Generation

    by  • May 21, 2014

    Fox Chase surgeon Robert G. Uzzo, MD, FACS, is recognized for teaching the next generation of urologic surgeons. He received the American Urologic Association’s Residents Committee Teaching Award at the organizations annual meeting in May 2014. A nationally recognized leader in urologic oncology, Robert G. Uzzo, MD, FACS, understands the value of sharing his knowledge...

    Read more →

    A Sea of Pink

    by  • May 13, 2014

    A sea of pink people. That’s pretty much all you saw at this past Sunday’s Susan G. Komen Race for the Cure to raise monies for breast cancer. Thousands of people: patients, survivors, families, nurses, doctors, friends, police, EMTs, advocates, volunteers, reporters, and so many others who are concerned. And in case you didn’t...

    Read more →

    My Experience Lobbying for Cancer Research on Capitol Hill

    by  • May 11, 2014

    Every once in a while, it’s important to get on a train and go to Washington to make your voice heard. At Fox Chase Cancer Center’s kind invitation, I went with Communications Director Lisa Bailey and fellow breast cancer survivor Kim Hagerich to the Capitol on May 8. We joined oncologists, researchers, cancer center...

    Read more →

    Gene Panels: Genetic Testing for Hereditary Cancer

    by  • May 1, 2014

    Genetic testing for hereditary cancer risk has been available for about 20 years.  A family history with more than one case of the same or related cancers, young cancers, or people who had cancer more than once might be offered genetic testing. This testing could be for many different gene mutations known to increase...

    Read more →

    The End of the Pap Test for Cervical Cancer?

    by  • April 24, 2014

    For decades, the Pap test had been the only test available to screen for cervical cancer.  The Pap is simple, safe, inexpensive, and most importantly, very effective. The number of cases of cervical cancer in the US has dropped by more than half over the past 30 years, mostly thanks to Pap testing.  But,...

    Read more →

    Robotic Salvage Prostatectomy: An Option for Men Whose Prostate Cancer has Returned after Initial Radiation Treatment

    by  • March 29, 2014

    Prostate cancer can be treated with either surgery or radiation therapy. For men who were initially treated with radiation therapy alone, prostate cancer can return in up to 40-50 percent of cases (Zelefsky et al). Prostate cancer recurrence after failed radiation treatment can significantly impact a patient’s quality of life and cause considerable morbidity...

    Read more →

    Advanced Surgical Options for the Treatment of Lymphedema

    by  • March 27, 2014

    Vascularized lymph node transfer is an innovative new surgical procedure used to treat lymphedema, a common condition for patients who have had their lymph nodes removed during the course of cancer treatment. Symptoms of lymphedema include fluid retention, tissue swelling and soreness of the extremities (arms, hands or legs). Research suggests that the frequency...

    Read more →

    State Funding is Vital to Support Life-Saving Biomedical Research

    by  • March 12, 2014

    In 2001, Pennsylvania allocated 19 percent of its Tobacco Master Settlement Agreement (MSA) funding annually to life-saving biomedical research through the Commonwealth Universal Research Enhancement (CURE) program. While these funds have led to research advances in cancer, cardiovascular disease, diabetes, infectious diseases, and public health, as well as grown Pennsylvania’s economy, they frequently come...

    Read more →

    How you can manage cancer-related fatigue

    by  • February 27, 2014

    Cancer related fatigue is a feeling of tiredness or exhaustion that is persistent and often not related to any activity. It is often not relieved by rest. People who feel fatigue often say that even a small effort, such as walking across a room, can seem like too much.  Other words used to describe...

    Read more →

    Prostate Cancer Screening: What is the PCA3 Test?

    by  • February 24, 2014

    Prostate cancer is the second leading cause of cancer death in men in the United States. The Federal Drug Administration (FDA) approved a type of blood test, prostate specific antigen (PSA), in 1986.  Since then, PSA has been widely used for prostate cancer screening and has led to the over diagnosis and treatment of...

    Read more →